|43.81||+2.86 / +6.98%|
As of 3:59pm ET
|43.82||+0.0088 / +0.02%|
The 9 analysts offering 12-month price forecasts for Tetraphase Pharmaceuticals Inc have a median target of 54.00, with a high estimate of 60.00 and a low estimate of 50.00. The median estimate represents a +23.26% increase from the last price of 43.81.
The current consensus among 10 polled investment analysts is to Buy stock in Tetraphase Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.